Private & confidential
Dr. Gao Jianhua
Chinese name: 高建华
Chief Physician, Professor . Plastic Surgery
Dr. Gao Jianhua is a chief physician, professor, and doctoral supervisor in the Department of Plastic and Reconstructive Surgery at Nanfang Hospital, Southern Medical University. With more than 30 years of experience, he specializes in keloid and scar treatment, breast reconstruction, and autologous fat grafting, and is a leading expert in Chinese plastic surgery.

Dr. Gao Jianhua
Over 30 Years
Years of Plastic Surgery Experience
175+
Academic Papers Published
50
Postgraduate Students Trained
About Dr. Gao Jianhua
Dr. Gao Jianhua serves as director and chief physician of the Department of Plastic and Reconstructive Surgery at Nanfang Hospital, Southern Medical University. After graduating from the First Military Medical University, he completed a master's degree in plastic surgery and earned a medical doctorate in Japan. Over a career spanning more than three decades, his clinical and research interests include keloid and hypertrophic scar biology, wound repair, breast reconstruction, and autologous fat grafting. He has led multiple National Natural Science Foundation projects and published extensively. He serves as vice president of the Chinese Medical Doctor Association's aesthetic and plastic surgery branch and as a standing committee member of the Chinese Medical Association's plastic surgery society.

- Director and Chief Physician, Department of Plastic and Reconstructive Surgery, Nanfang Hospital, Southern Medical University
- Professor and Doctoral Supervisor; Guest Professor at Nippon Medical School, Japan
- First author of a National Science and Technology Progress Award, Second Class; recipient of the Paul Janssen Medical Research Award
- Principal investigator of five National Natural Science Foundation of China projects; holder of three national utility patents
- Vice President of the aesthetic and plastic surgery branch, Chinese Medical Doctor Association; standing committee member of the Chinese Medical Association plastic surgery society
Dr. Gao Jianhua ’s Three Key Areas of Expertise
Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.
Keloid and Hypertrophic Scar Treatment
Comprehensive surgical and non-surgical management of keloid and hypertrophic scars, including scar excision, intralesional steroid injection, adjuvant radiotherapy, and long-term pressure therapy, including silicone gel sheeting, with individualized recurrence prevention tailored to each patient's scar type, location, and previous treatment response.
Breast Augmentation and Reconstruction
Natural fat transfer and implant-based breast surgery for augmentation, asymmetry correction, and post-mastectomy reconstruction, combining autologous fat grafting with adipose-derived stromal cell enrichment to improve graft retention, restore soft natural volume, and enhance long-term aesthetic and reconstructive outcomes for women.
Autologous Fat Grafting and Facial Rejuvenation
Fat harvesting, purification, and layered injection for facial volume restoration, wrinkle correction, and body contouring, using gentle low-pressure techniques to maximize fat cell survival and achieve smooth, long-lasting, natural-looking results with minimal downtime, reduced risk of complications, and high patient satisfaction.
More:Additional specialties include scar revision, removal of skin tumors and soft-tissue masses, wound repair, and comprehensive aesthetic plastic surgery of the face and body.
Selected cases, research & publications
Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Surgical Treatment of Keloids and Hypertrophic Scars
This clinical research examined keloid and hypertrophic scar surgery, including scar excision and recurrence prevention, and analyzed fibroblasts from different regions of keloid tissue. The findings help surgeons improve treatment planning for patients seeking keloid scar removal and resistant hypertrophic scar therapy.
Related link: https://doi.org/10.1097/01.prs.0000270293.93612.7b
2. Fat Grafting with Adipose Stromal Cells for Breast Augmentation
A clinical study on supplementing autologous fat grafts with adipose-derived stromal cells to improve fat retention in cosmetic breast augmentation. It evaluated surgical outcomes and graft survival, offering evidence for women considering natural fat transfer breast augmentation with improved volume retention and soft, natural results.
3. p53 Gene Polymorphism and Hypertrophic Scar after Caesarean Section
This genetic study investigated the relationship between the p53 codon-72 polymorphism and hypertrophic scar formation after caesarean section. It provides molecular insight that may guide scar risk assessment and preventive treatment for women who develop raised, itchy scars after surgery.
Related link: https://pmc.ncbi.nlm.nih.gov/articles/PMC3991505/
4. Apoptosis Signaling in Keloid and Hypertrophic Scar Fibroblasts
Basic research on Fas-mediated apoptotic signal transduction in keloid and hypertrophic scar fibroblasts, exploring why scar cells resist normal cell death. Understanding this pathway supports the development of targeted therapies for patients with persistent keloid scars and excessive scar tissue.
Related link: https://doi.org/10.1097/01.prs.0000258851.47193.06
5. Duffy Antigen Receptor and Keloid Pathogenesis
A molecular study of the Duffy antigen receptor for chemokines and its role in keloid formation. It showed how this receptor regulates chemokine secretion and fibroblast migration, providing a potential molecular target for developing new keloid treatments and long-term recurrence control.
Related link: https://doi.org/10.1016/j.gene.2015.05.071
6. Gap Junction Communication in Scar Fibroblasts
This study examined gap junctional intercellular communication and connexin expression in keloid and hypertrophic scar fibroblasts. The results help clarify how abnormal cell-to-cell signaling contributes to scar overgrowth, informing improved clinical strategies for hypertrophic scar prevention and scar revision surgery.
Related link: https://doi.org/10.1097/01.prs.0000255539.99698.f4
Where Dr. Gao Jianhua practices

Nanfang Hospital, Southern Medical University
Chinese name: 南方医科大学南方医院
Nanfang Hospital, founded in 1941 as a wartime rear hospital and now a national regional medical center of Southern Medical University, is a Grade-A tertiary hospital holding 5 national key disciplines, 17 national key specialties and a nationally leading nephrology program.
Since 1941
85 years of care
2,225
Licensed beds
17
National key specialties
3.32 million (2021)
Licensed beds
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
Why patients travel to China for treatment
Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.
Clinical capability at international standard
Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.
Diagnostics and treatment in days, not months
A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.
Transparent, itemised pricing
Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.
Policy channels that open the door
China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
Consulting this physician, step by step
From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
- Share your storyA private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
- Records review & matchingOrisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
- Your consultationAppointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
- Reports & follow-upTranslated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Gao Jianhua?
Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Information Sources
This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.
- Nanfang Hospital official physician profile: https://www.nfyy.com/ks/zk/mrzx/doctor_5904.html
- Plastic and Reconstructive Surgery, PubMed DOI: https://doi.org/10.1097/01.prs.0000270293.93612.7b
- Gene journal article, PubMed DOI: https://doi.org/10.1016/j.gene.2015.05.071
Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.
Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Gao Jianhua.